GSK plc (OTC Pink - Current Information:GLAXF)

17.28
Delayed Data
As of Feb 02
 -0.12 / -0.69%
Today’s Change
13.48
Today|||52-Week Range
29.25
-1.17%
Year-to-Date
GSK's Daprodustat Drug for Anemia Due to CKD Gets FDA Nod
Feb 02 / Zacks.com - Paid Partner Content
Moderna (MRNA) RSV Jab For Older Adults Gets FDA Breakthrough Tag
Jan 31 / Zacks.com - Paid Partner Content
WELCH & FORBES LLC Buys 3, Sells 2 in 4th Quarter
Feb 02 / GuruFocus News - Paid Partner Content
GSK Gears Up to Report Q4 Earnings: What's in the Cards?
Jan 30 / Zacks.com - Paid Partner Content
Vanguard Health Care Fund Exits Top Holding Bristol-Myers Squibb, Buys Merck
Feb 02 / GuruFocus News - Paid Partner Content
FDA Pulls EUA Granted to AstraZeneca's (AZN) Evusheld
Jan 27 / Zacks.com - Paid Partner Content
GSK's Beats on Q4 Earnings & Sales, Issues Upbeat 2023 Outlook
Feb 01 / Zacks.com - Paid Partner Content
Earnings Preview: Bristol Myers Squibb (BMY) Q4 Earnings Expected to Decline
Jan 26 / Zacks.com - Paid Partner Content
GSK (GSK) Q4 Earnings and Revenues Top Estimates
Feb 01 / Zacks.com - Paid Partner Content
GSK (GSK) Gains As Market Dips: What You Should Know
Jan 25 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close17.40
Today’s open17.58
Day’s range17.28 - 17.79
Volume1,234
Average volume (3 months)8,489
Market cap$72.8B
Data as of 02/02/2023

Growth & Valuation

Earnings growth (last year)-18.64%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+7.30%
P/E ratio--
Price/Sales2.35
Price/Book3.49

Competitors

 Today’s
change
Today’s
% change
GSKGlaxoSmithKline-0.34-0.97%
----
ZTSZoetis Inc+3.19+1.90%
----
Data as of 4:00pm ET, 02/02/2023

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$46.9B
Annual profit (last year)$6.0B
Net profit margin12.85%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Middlesex, Greater London

Forecasts

Chart unavailable